Mavik® trandolapril tablets 4mg, 100 count bottle, Rx only, Manufactured by Halo Pharmaceutical Inc., Whippany, NJ for Abbott Laboratories, North Chicago, IL 60064, USA
Published August 28, 2013 · Recall initiated: August 1, 2013
Summary
FDA records drug Class III recall D-901-2013, published August 28, 2013 and initiated August 1, 2013. Recalling firm: AbbVie Inc.; Status: Terminated; Reported quantity: 704 bottles; Lot: Lot 22033GY. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Incorrect Package Insert; product packaged with outdated version of the insert
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- AbbVie Inc.
- Distributor
- Nationwide
- Lot
- Lot 22033GY
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAPRED MILD, prednisolone acetate ophthalmic suspension, USP, 0.12%, 10 mL, Sterile, Rx only, Allergen, Inc., anJune 3, 2026
- FDARefresh P.M., (Mineral Oil 42.5%, White Petrolatum 57.3%) Lubricant Eye Ointment, Net wt, 0.12 oz (3.5g) Tube,October 2, 2024
- FDARefresh LACRI-LUBE, (42.5% Mineral Oil, 57.3% White Petrolatum) Lubricant Eye Ointment, Net wt, 0.12 oz (3.5g)October 2, 2024
- FDASynthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bottle, Rx Only AbbVie Inc. NorthNovember 15, 2023
- FDANata Komplete, containing one 30-count bottle of multi-vitamin tablets (imprinted 909), Manufactured for W.H.August 28, 2013
- FDAMaalox Extra Strength Antacid with Anti-Gas (calcium carbonate and simethicone) chewable tablets, 1000 mg/60August 28, 2013
Questions about this recall
Was Mavik® trandolapril tablets 4mg, 100 count bottle, Rx only, Manufactured by Halo Pharmaceutical Inc., Whippany, NJ for Abbott Laboratories, North Chicago, IL 60064, USA recalled?
Yes. FDA published recall D-901-2013 on August 28, 2013. Reported hazard: Labeling: Incorrect Package Insert; product packaged with outdated version of the insert
What should I do if I have this product?
Voluntary: Firm initiated · Letter